BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2000 TO 2009]

Results 41-60 of 68 (Search time: 0.006 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
412003Overall survival is not a realistic endpoint for clinical trials in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancerDi Leo, A.; Bleiberg, H.; BUYSE, MarcJournal ContributionA1
422003Validation of biomarkers as surrogates for clinical endpointsBUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc; RENARD, Didier; BURZYKOWSKI, Tomasz; GEYS, Helena; MOLENBERGHS, GeertBook SectionB3
432003Comparaison entre LV5FU2 bi-mensuel et FUFOL mensuel pendant 24 ou 36 semaines en traitement adjuvant des cancers du colon stade II et III: résultats à 4 ans d'une étude randomiséeBUYSE, Marc; André, Thierry; Artru, P.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Piedbois, P.; Flesch, M.; Tubiana-Mathieu, N.; de Gramont, A.Journal ContributionA2
442003Simplified hierarchical linear models for the evaluation of surrogate endpointsTIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; RENARD, Didier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Parmar, Mahesh; Stijnen, Theo; Wolfinger, RussJournal ContributionA1
452003Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancerBUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, JanJournal ContributionA1
462003Validation of a longitudinally measured surrogate for a time-to-event endpointRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, LucJournal ContributionA1
472003Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized TrialBUYSE, Marc; André, Thierry; Colin, P.; Liouvet, C.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Colbert, N.; Boaziz, C.; Piedbois, P.; Tubiana-Mathieu, N.; Boutan-Laroze, A.; Flesch, M.; Billau, V.; de Gramont, A.Journal ContributionA1
482002Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early cancer: first results of the ATAC randomized trialBUYSE, MarcJournal ContributionA1
492002Statistical challenges in the evaluation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, ArielJournal ContributionA1
502002Challenges in the methodology for the validation of surrogate endpoints in randomized trialsMOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, TomaszProceedings PaperC2
512002The role of colony stimulating factors in small cell cancer: why the question is still unresolvedTrillet-Lenoir, V.; Piedbois, R.; BUYSE, MarcJournal ContributionA1
522002Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancerDiLeo, A.; BUYSE, MarcJournal ContributionA1
532002Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomesRENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
542001Methodology for the validation of surrogate endpoints in multiple randomized experimentsMOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, MarcProceedings PaperC2
552001Methodology of the validation of surrogate endpoints in multiple randomized experimentsMOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, MarcProceedings PaperC2
562001Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpointsBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, DidierJournal ContributionA1
572001Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancerBUYSE, Marc; Thirion, Pierre; Carlson, Robert; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, PascalJournal ContributionA1
582001Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomesMOLENBERGHS, Geert; GEYS, Helena; BUYSE, MarcJournal ContributionA1
592001Should Dukes' B patients receive adjuvant therapy? A statistical perspectiveBUYSE, Marc; Piedbois, PJournal ContributionA1
602000Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpointsBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, DidierProceedings PaperC1
show all